Bleichroeder Acquisition Corp. I Files 8-K

TL;DR

BACQ filed an 8-K detailing its share structure and rights. Nothing major, just corporate housekeeping.

AI Summary

Bleichroeder Acquisition Corp. I filed an 8-K on September 23, 2025, reporting on various corporate events. The filing includes information about its Class Ordinary Shares and Rights, which entitle holders to receive a fraction of a Class Ordinary Share. The company is incorporated in the Cayman Islands and its fiscal year ends on December 31.

Why It Matters

This 8-K filing provides an update on the corporate structure and share details for Bleichroeder Acquisition Corp. I, which is relevant for investors tracking the company's status.

Risk Assessment

Risk Level: low — This filing is primarily administrative and does not contain significant financial or operational news that would immediately impact the company's risk profile.

Key Players & Entities

• Bleichroeder Acquisition Corp. I (company) — Registrant
• September 23, 2025 (date) — Date of earliest event reported
• Cayman Islands (jurisdiction) — State or other jurisdiction of incorporation
• Class Ordinary Shares (security) — Type of shares issued
• Rights (security) — Associated rights for shareholders

FAQ

Key Financial Figures

• $0.0001 — LC Class A ordinary shares, par value $0.0001 per share BACQ The Nasdaq Stock Mar

Filing Documents

• ea0258388-8k425_bleich1.htm (8-K) — 49KB
• ea025838801ex99-1_bleichro1.htm (EX-99.1) — 10KB
• 0001213900-25-090358.txt ( ) — 282KB
• bacq-20250923.xsd (EX-101.SCH) — 4KB
• bacq-20250923_def.xml (EX-101.DEF) — 27KB
• bacq-20250923_lab.xml (EX-101.LAB) — 37KB
• bacq-20250923_pre.xml (EX-101.PRE) — 25KB
• ea0258388-8k425_bleich1_htm.xml (XML) — 7KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. As previously disclosed, on August 13, 2025, Bleichroeder Acquisition Corp. I (which will be renamed Inflection Point Acquisition Corp. IV) ("Inflection Point"), entered into a Business Combination Agreement (the "Business Combination Agreement"), with IPDX Merger Sub, Inc., a direct wholly-owned subsidiary of Inflection Point ("Merger Sub"), and Merlin Labs, Inc., a leading developer of assured, autonomous flight technology for defense customers ("Merlin Labs"), pursuant to which, among other things and subject to the terms and conditions therein, Merger Sub will merge with and into Merlin Labs, with Merlin Labs continuing as the surviving company and a wholly-owned subsidiary of Inflection Point (the transactions contemplated by the Business Combination Agreement, the "Business Combination"). On September 23, 2025, Merlin Labs issued a press release announcing a strategic partnership (the "Strategic Partnership") with GE Aerospace ("GE Aerospace") to pursue autonomy core development. This next-generation autonomy and pilot-assist platform will be designed to bring AI-enabled capabilities to existing and future military and civil aircraft and meet the growing demand for crew reduction and uncrewed flight capabilities. Merlin Labs believes the Strategic Partnership complements Merlin Labs' and GE Aerospace's capabilities and technologies and that GE Aerospace's proven expertise in flight management systems and open system architecture, coupled with Merlin Labs' autonomy software suite, avionics packages, and Datalink solutions, will provide operators with a scalable, certifiable, and future-ready solution to meet the growing demand for crew reduction, SPO, and uncrewed flight capabilities. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated into this Item 7.01 by reference herein. The information furnished in this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of S

01. Other Events

Item 8.01. Other Events. Inflection Point and Merlin Labs are contemplating raising additional funds in private placement transactions exempt from the registration requirements of the Securities Act in order to support the Strategic Partnership. The private placement transactions will be conditioned upon, among other things, the consummation of the Business Combination. Additional Information The Business Combination will be submitted to shareholders of Inflection Point for their consideration. In connection with the Business Combination, Inflection Point intends to file a Registration Statement with the U.S. Securities and Exchange Commission (the "SEC"), which will include a proxy statement/prospectus and certain other related documents, which will serve as both the proxy statement to be distributed to shareholders of Inflection Point in connection with its solicitation for proxies for the vote by its shareholders in connection with the Business Combination and other matters to be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued to securityholders of Inflection Point and equityholders of Merlin Labs in connection with the completion of the Business Combination. After the Registration Statement is declared effective, Inflection Point will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the Business Combination (the "Record Date"). This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Inflection Point will send to its shareholders in connection with the Business Combination. 1 INVESTORS AND SECURITYHOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BE

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K and certain of the exhibits hereto contain certain statements that are not historical facts but may be considered "forward-looking statements" within the meaning of Section 27(a) of the Securities Act and Section 21(e) of the Exchange Act. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook" or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the Business Combination, the estimated or anticipated future results and benefits of Inflection Point following the Business Combination ("New Merlin Labs"), including the likelihood and ability of the parties to successfully consummate the Business Combination, future opportunities for New Merlin Labs and other statements that are not historical facts. 2 These statements are based on the current expectations of the management of Inflection Point and/or Merlin Labs and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Inflection Point and Merlin Labs. These statements are subject to a number of risks and uncertainties regarding Merlin Labs' business and the Business Combination, and actual results may differ materially. These risks and uncertai

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated September 23, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 4 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BLEICHROEDER ACQUISITION CORP. I Date: September 23, 2025 By: /s/ Michael Blitzer Name: Michael Blitzer Title: President and Chief Executive Officer 5

View Full Filing

View this 8-K filing on SEC EDGAR